GlassScriptPhysician profile
Jason Finkelstein
NPI 1750355103
$26,140.17
in general payments reported to CMS, 2019-2025
47 companies · $1,094 in 2025
The $1,094 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,058 · 2020: $3,791 · 2021: $8,509 · 2022: $3,048 · 2023: $1,714 · 2024: $3,926 · 2025: $1,094.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,283 · Travel and Lodging: $1,451.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,282.68 |
| Travel and Lodging | $1,451.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $8,572.71 | 2021-2025 | Onyx Frontier, Abre |
| Astrazeneca Pharmaceuticals LP | $5,486.61 | 2019-2024 | Farxiga |
| Medtronic Vascular, INC. | $1,936.48 | 2019-2020 | |
| Abbott Laboratories | $1,564.20 | 2019-2025 | Cardiomems, Ensite, Aveir |
| E.R. Squibb & Sons, L.L.C. | $1,534.49 | 2019-2025 | Camzyos, Eliquis |
| Novartis Pharmaceuticals Corporation | $880.22 | 2019-2025 | |
| Abiomed | $835.07 | 2019-2025 | Impella |
| Impulse Dynamics (USA) INC. | $761.39 | 2019-2025 | Optimizer, Optimizer |
| Pfizer INC. | $708.82 | 2019-2023 | |
| Biotronik INC. | $546.85 | 2019-2025 | Biomonitor, Renamic Neo |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $496.18 | 2019-2025 | Lifevest |
| Janssen Pharmaceuticals, INC | $381.35 | 2019-2024 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $360.89 | 2020-2024 | Jardiance |
| Merck Sharp & Dohme LLC | $359.51 | 2021-2025 | Verquvo |
| Chiesi USA, INC. | $268.82 | 2019-2022 |
Show all 46 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $217.74 | 2019 | |
| Lexicon Pharmaceuticals, INC. | $186.42 | 2023-2024 | Inpefa |
| Scpharmaceuticals INC. | $111.06 | 2024-2025 | |
| Amgen INC. | $108.31 | 2019-2024 | Repatha |
| Boston Scientific Corporation | $81.55 | 2022-2025 | Apollo Esg System |
| Sanofi-Aventis U.S. LLC | $67.95 | 2019-2022 | |
| Novo Nordisk INC | $61.57 | 2025 | Wegovy |
| Vifor Pharma, INC. | $59.38 | 2020-2023 | Veltassa |
| Portola Pharmaceuticals, LLC | $54.75 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $40.20 | 2024-2025 | Uptravi, Opsumit |
| Philips North America LLC | $32.34 | 2020-2025 | Ecc Solutions |
| Daiichi Sankyo INC. | $29.09 | 2023 | Injectafer |
| Bayer Healthcare Pharmaceuticals INC. | $27.33 | 2025 | |
| Liquidia Technologies, INC. | $26.37 | 2025 | Yutrepia |
| Tactile Systems Technology INC | $24.93 | 2019-2021 | |
| Veryan Medical Incorporated | $24.49 | 2021 | |
| Recor Medical INC | $24.35 | 2025 | Paradise Ultrasound Renal Denervation System |
| Pharmacosmos Therapeutics INC. | $24.33 | 2022 | |
| Bard Access Systems, INC. | $24.20 | 2019 | |
| Kiniksa Pharmaceuticals, LTD. | $23.43 | 2023 | Arcalyst |
| Alnylam Pharmaceuticals INC. | $23.12 | 2024 | Onpattro |
| Inari Medical, INC. | $22.98 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Amarin Pharma, INC. | $22.62 | 2021 | |
| Shockwave Medical, INC | $21.06 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Acist Medical Systems, INC. | $18.00 | 2021 | |
| Stryker Corporation | $17.97 | 2025 | Clottriever Bold Catheter |
| Edwards Lifesciences Corporation | $17.42 | 2019 | |
| Inspire Medical Systems, INC. | $15.64 | 2023 | Inspire |
| Baxter Healthcare | $14.07 | 2025 | Hillrom - Cardiac Ambulatory Monitor |
| Regeneron Healthcare Solutions, INC. | $12.45 | 2019 | |
| Gilead Sciences, INC. | $11.46 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$88,509.36 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Finkelstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.